Chulkina M.M., Lebedeva E.S., Holmuhamedov E.L., Ataullakhanov R.I. Ezrin hinge region peptid TEKKRRETVEREKE mediated fibroblast to myofibroblast differentiation in NIH/3T3 cells. Immunologiya. 2017; 38(1): 4-11. (in Russian)
Chulkina M.M., Lebedeva E.S., Pichugin A.V., Holmuhamedov E.L., Ataullakhanov R.I. Ezrin hinge region peptid TEKKRRETVEREKE stimulated Mitogen-Activated Protein Kinase/Extracellular-Signal-Regulated Kinase (MAP kinase/ERK) activity in murine fibroblast NIH/3T3. Immunologiya. 2017, 38(4): 172-9. (in Russian)
Dudchenko M.A., Lysenko B.F., Chelishvili A.L., Katlinski A.V., Ataullakhanov R.R. Combination therapy of trophic ulcers. Lechashchiy vrach. 2002; 10: 72-5. (in Russian)
Lazebnik L.B., Zvenigorodskaia L.A., Firsakova V., Pichygin A.V., Ataullakhanov R.I. Use of the immunomodulator hepon in the treatment of erosive peptic ulcer lesions. Eksperimental’naya i klinicheskaya gastroenterologiya. 2003; 3: 17-20. (in Russian)
Kirienko A.I., Ataullakhanov R.I., Bogachev V., Bogdanets L.I., Pichugin A.V., Zhuravleva O.V. Trophic venous ulcers and their relationship with the immune status. Angiologiya i sosudistaya khirurgiya. 2007; 13(1):76-85. (in Russian)
Sixt M. Cell migration: fibroblasts find a new way to get ahead. J. Cell Biol. 2012; 197(3): 347-9. doi: 10.1083/jcb.201204039.
Klingberg F., Hinz B., White E.S. The myofibroblast matrix: implications for tissue repair and fibrosis. J. Pathol. 2013; 229(2): 298-309. doi:10.1002/path.4104.
Tracy L.E., Minasian R.A., Caterson E.J. Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. Adv. Wound Care (New Rochelle). 2016; 5(3):119-36.
Cichy J., Pure E. The liberation of CD44. J. Cell. Biol. 2003; 161: 839-43.
Mythreye K., Blobe G.C. Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion. Cell Signal. 2009; 21: 1548-58.
Kirschner N., Haftek M., Niessen C.M., Behne M.J., Furuse M., Moll I., Brandner J.M. CD44 regulates tight-junction assembly and barrier function. J. Invest Dermatol. 2011; 131: 932-43.
Hiraga T., Ito S., Nakamura H. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 2013; 73: 4112-22.
Seiki M. The cell surface: The stage for matrix metalloproteinase regulation of migration. Curr Opin. Cell. Biol. 2002; 14: 624-32.
Twarock S., Tammi M.I., Savani R.C., Fischer J.W. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J. Biol. Chem. 2010; 285: 23276-84.
Mellor L., Knudson C.B., Hida D., Askew E.B., Knudson W. Intracellular domain fragment of CD44 alters CD44 function in chondrocytes. J. Biol. Chem. 2013; 288: 25838-50.
Misra S., Hascall V.C., Markwald R.R., Ghatak S. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front. Immunol. 2015; 6: 201. doi: 10.3389/fimmu.2015.00201.
Piotrowicz R.S., Damaj B.B., Hachicha M., Incardona F., Howell S.B., Finlayson M. A6 peptide activates CD44 adhesive activity, induces FAK and MEK phosphorylation, and inhibits the migration and metastasis of CD44-expressing cells. Mol. cancer therapeutics. 2011; 10(11): 2072-82. doi: 10.1158/1535-7163.MCT-11-0351.
Yang X., Sarvestani S.K., Moeinzadeh S., He X., Jabbari E. Effect of CD44 binding peptide conjugated to an engineered inert matrix on maintenance of breast cancer stem cells and tumorsphere formation. PloS one. 2013; 8(3): e59147. doi: 10.1371/journal.pone.0059147.
Finlayson M. Modulation of CD44 Activity by A6-Peptide. Frontiers in immunology. 2015; 6: 135. doi: 10.3389/fimmu.2015.00135.
Cho S.W., Kim S., Kim J.M., Kim J.S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol. 2013; 31(3): 230-2. doi: 10.1038/nbt.2507.
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome engineering via Cas9. Science. 2013; 339(6121): 823-6. doi: 10.1126/science.1232033.
Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013; 8(11):2281-308. doi: 10.1038/nprot.2013.143.
Hsu P.D., Scott D.A., Weinstein J.A., Ran F.A., Konermann S., Agarwala V. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013; 31(9): 827-32. doi: 10.1038/nbt.2647.
Tarasevich A., Filatov A., Pichugin A., Mazurov D. Monoclonal antibody profiling of cell surface proteins associated with the viral biofilms on HTLV-1 transformed cells. Acta Virol. 2015; 59(3): 247-56.
Webber J., Jenkins R.H., Meran S., Phillips A., Steadman R. Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan. Am. J. Pathol. 2009; 175(1): 148-60. doi: 10.2353/ajpath.2009.080837.
Bustin S.A., Benes V., Nolan T., Pfaffl M.W. Quantitative real-time RT-PCR-a perspective., J. Mol. Endocrinol. 2005; 34(3): 597-601.
Bourguignon L.Y., Xia W., Wong G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J. Biol. Chem. 2009; 284: 2657-71.
Suwan K., Choocheep K., Hatano S., Kongtawelert P., Kimata K., Watanabe H. Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts. J. Biol. Chem. 2009; 284: 8596-604.
Acharya P.S., Majumdar S., Jacob M., Hayden J., Mrass P., Weninger W., Assoian R.K., Puré E. Fibroblast migration is mediated by CD44-dependent TGF beta activation. J. Cell. Sci. 2008; 121(9): 1393-402. doi: 10.1242/jcs.021683.
Tsuneki M., Madri J.A. CD44 Influences fibroblast behaviors via modulation of cell-cell and cell-matrix interactions, affecting Survivin and Hippo pathways. J. Cell Physiol. 2016; 231(3): 731-43. doi: 10.1002/jcp.25123.
Knudson W., Aguiar D.J., Hua Q., Knudson C.B. CD44-anchored hyaluronan-rich pericellular matrices: An ultrastructural and biochemical analysis. Exp. Cell Res. 1996; 228: 216-28.
Simpson R.M., Meran S., Thomas D., Stephens P., Bowen T., Steadman R., Phillips A. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. Am. J. Pathol. 2009; 175(5): 1915-28. doi: 10.2353/ajpath.2009.090045.
Midgley A.C., Rogers M., Hallett M.B., Clayton A., Bowen T., Phillips A.O., Steadman R. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblasts differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J. Biol. Chem. 2013; 288(21): 14824-38. doi: 10.1074/jbc.M113.451336
Takeda M., Ogino S., Umemoto R., Sakakura M., Kajiwara M., Sugahara K.N. et al. Ligand-induced structural changes of the CD44 hyaluronan-binding domain revealed by NMR. J Biol Chem. 2006; 281(52): 40089-95.